NCT00103038 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 155
- units
- Participants
- groups
- description
- Study patients: adult patients with high grade primary malignant brain tumors or with known or suspected brain metastases from histologically confirmed primary cancer Study procedures: patients will receive IV ferumoxytol (maximum dose 4 mg/kg, over at least 15 minutes) beginning approximately 15 seconds after start of 3T DSC-MRI and GBCA IV approximately 1 minute and 50 seconds after start of 3T DCE-MRI on day 1. Patients will also undergo MRI without contrast at baseline (before and on day 2. Imaging with ferumoxytol, GBCA and without contrast repeats every 3 weeks for a total of 6 more imaging sessions over up to 5 years. 3 Tesla Magnetic Resonance Imaging: Undergo 3T MRI Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Undergo 3T DCE-MRI Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging: Undergo 3T DSC-MRI Ferumoxytol: Given IV Gadolinium: Given IV MRI-Based Angiogram: Undergo MRA
- id
- BG000
- title
- Malignant Brain Tumor Patients Undergoing Brain MRI (With Both Ferumoxytol and Gadolinium)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.81
- value
- 51.71
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 150
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 147
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 67
- title
- Glioblastoma
- measurements
- group Id
- BG000
- value
- 19
- title
- Anaplastic Astrocytoma
- measurements
- group Id
- BG000
- value
- 19
- title
- Anaplastic Oligodendroglioma
- measurements
- group Id
- BG000
- value
- 4
- title
- Primary CNS Lymphoma
- measurements
- group Id
- BG000
- value
- 18
- title
- Brain metastasis
- measurements
- group Id
- BG000
- value
- 17
- title
- Other
- measurements
- group Id
- BG000
- value
- 11
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Type of brain malignancy
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 155
- units
- Participants
- groups
- description
- Study patients: adult patients with high grade primary malignant brain tumors or with known or suspected brain metastases from histologically confirmed primary cancer Study procedures: patients will receive IV ferumoxytol (maximum dose 4 mg/kg, over at least 15 minutes) beginning approximately 15 seconds after start of 3T DSC-MRI and GBCA IV approximately 1 minute and 50 seconds after start of 3T DCE-MRI on day 1. Patients will also undergo MRI without contrast at baseline (before and on day 2. Imaging with ferumoxytol, GBCA and without contrast repeats every 3 weeks for a total of 6 more imaging sessions over up to 5 years. 3 Tesla Magnetic Resonance Imaging: Undergo 3T MRI Dynamic Contrast-Enhanced Magnetic Resonance Imaging: Undergo 3T DCE-MRI Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging: Undergo 3T DSC-MRI Ferumoxytol: Given IV Gadolinium: Given IV MRI-Based Angiogram: Undergo MRA
- id
- BG000
- title
- Malignant Brain Tumor Patients Undergoing Brain MRI (With Both Ferumoxytol and Gadolinium)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.81
- value
- 51.71
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 70
- title
- Female
- measurements
- group Id
- BG000
- value
- 85
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 150
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 147
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 67
- title
- Glioblastoma
- measurements
- group Id
- BG000
- value
- 19
- title
- Anaplastic Astrocytoma
- measurements
- group Id
- BG000
- value
- 19
- title
- Anaplastic Oligodendroglioma
- measurements
- group Id
- BG000
- value
- 4
- title
- Primary CNS Lymphoma
- measurements
- group Id
- BG000
- value
- 18
- title
- Brain metastasis
- measurements
- group Id
- BG000
- value
- 17
- title
- Other
- measurements
- group Id
- BG000
- value
- 11
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Type of brain malignancy
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle